What is the current valuation of the organ on-chip market in France as of 2024?

The organ on-chip market in France was valued at $15.4 Million in 2024. Read More

What is the projected market valuation for the organ on-chip market in France by 2035?

The projected valuation for the organ on-chip market in France is $36.7 Million by 2035. Read More

What is the expected CAGR for the organ on-chip market in France during the forecast period 2025 - 2035?

The expected CAGR for the organ on-chip market in France during the forecast period 2025 - 2035 is 8.21%. Read More

Which organ-on-chip types are expected to show significant growth in the French market?

Liver-on-Chip and Lung-on-Chip are expected to show significant growth, with valuations projected at $7.0 Million and $5.8 Million respectively by 2035. Read More

What are the primary applications driving the organ on-chip market in France?

The primary applications driving the market include Toxicology Research, projected to reach $18.0 Million, and Drug Discovery, expected to grow to $12.0 Million by 2035. Read More

Who are the key players in the organ on-chip market in France?

Key players in the organ on-chip market include Emulate Inc, Mimetas, TissUse, and Organovo Holdings Inc. Read More

What is the expected market size for the Kidney-on-Chip segment in France by 2035?

The Kidney-on-Chip segment is expected to reach a market size of $4.0 Million by 2035. Read More

How do pharmaceutical companies contribute to the organ on-chip market in France?

Pharmaceutical companies are projected to contribute $14.25 Million to the organ on-chip market in France by 2035. Read More

What is the anticipated market size for the Skin-on-Chip segment in France by 2035?

The Skin-on-Chip segment is anticipated to reach a market size of $2.5 Million by 2035. Read More

What is the expected growth for the Blood-Brain Barrier-on-Chip segment in France?

The Blood-Brain Barrier-on-Chip segment is expected to grow to $2.8 Million by 2035. Read More

France Organ On Chip Market

ID: MRFR/MED/49553-HCR

200 Pages

Nidhi Mandole

Last Updated: April 06, 2026

France Organ-On-Chip Market Research Report: Size, Share, Trend Analysis By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip), By Applications (Drug Discovery, Toxicology Research, Others) and By End-User (Pharmaceutical Companies, Research Organizations, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Organ Type (USD Million)
  1. 4.1.1 Lung-on-Chip
  2. 4.1.2 Heart-on-Chip
  3. 4.1.3 Liver-on-Chip
  4. 4.1.4 Intestine-on-Chip
  5. 4.1.5 Kidney-on-Chip
  6. 4.1.6 Skin-on-Chip
  7. 4.1.7 Blood-Brain Barrier-on-Chip
  8. 4.1.8 Human-on-Chip
2. 4.2 Life Sciences, BY Application (USD Million)
  1. 4.2.1 Drug Discovery
  2. 4.2.2 Toxicology Research
  3. 4.2.3 Others
3. 4.3 Life Sciences, BY End-User (USD Million)
  1. 4.3.1 Pharmaceutical Companies
  2. 4.3.2 Research Organizations
  3. 4.3.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Emulate Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Mimetas (NL)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 TissUse (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Organovo Holdings Inc (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Synlogic Inc (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hesperos Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 InSphero AG (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Reinnervate Ltd (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 FRANCE MARKET ANALYSIS BY ORGAN TYPE
3. 6.3 FRANCE MARKET ANALYSIS BY APPLICATION
4. 6.4 FRANCE MARKET ANALYSIS BY END-USER
5. 6.5 KEY BUYING CRITERIA OF LIFE SCIENCES
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF LIFE SCIENCES
8. 6.8 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
9. 6.9 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 SUPPLY / VALUE CHAIN: LIFE SCIENCES
11. 6.11 LIFE SCIENCES, BY ORGAN TYPE, 2024 (% SHARE)
12. 6.12 LIFE SCIENCES, BY ORGAN TYPE, 2024 TO 2035 (USD Million)
13. 6.13 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
14. 6.14 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 LIFE SCIENCES, BY END-USER, 2024 (% SHARE)
16. 6.16 LIFE SCIENCES, BY END-USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY ORGAN TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

France Life Sciences Market Segmentation

Life Sciences By Organ Type (USD Million, 2025-2035)

Lung-on-Chip
Heart-on-Chip
Liver-on-Chip
Intestine-on-Chip
Kidney-on-Chip
Skin-on-Chip
Blood-Brain Barrier-on-Chip
Human-on-Chip

Life Sciences By Application (USD Million, 2025-2035)

Drug Discovery
Toxicology Research
Others

Life Sciences By End-User (USD Million, 2025-2035)

Pharmaceutical Companies
Research Organizations
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”